Daktronics, Inc.

Reviews Daktronics’ record FY26 net sales of $838.7 million (up 10.9%), Q4 net sales of $208.6 million (up 20.9%), EPS inflection from a prior-year loss to $0.92 GAAP and $1.05 adjusted, and operating-margin expansion to 7.3%, arguing that strong orders of $860.8 million and a $356.2 million backlog validate the strategic plan and support continued upside. While broadly positive on demand, margins, and backlog visibility, it flags technical signals (MACD, momentum, moving averages) that suggest near-term downside risk and encourages investors to monitor tariff dynamics, order trends, and margin sustainability.

Frames Daktronics as in an execution‑driven growth phase with Q3 FY26 sales rising 21.6% year over year to $181.9 million, GAAP EPS swinging from $$-0.36$$ to 0.06, and backlog increasing from roughly $273 million to $342 million, while noting that profitability is constrained by tariffs (~$6 million in the quarter) and a lower‑margin live‑events mix. Highlights transportation orders up 130% year over year, backlog duration into Q4 and early FY27, tariff resilience, and early SaaS/subscription initiatives as underappreciated drivers, but stresses that further operational self‑help and backlog conversion are needed to translate growth into sustainably stronger margins.

Summarizes Zacks’ upgrade of Daktronics from “hold” to “strong‑buy” after the company beat Q2 FY26 estimates with EPS of $0.35 versus $0.27 expected and revenue of $229.25 million versus $213.93 million, noting that the MarketBeat consensus remains Buy based on one Strong Buy and one Hold. The note acknowledges a rich headline P/E of about 169x at a ~$22 share price but points to attractive PEG, healthy beta‑adjusted growth, modest leverage (debt‑to‑equity 0.18), and solid liquidity ratios as support for a constructive, valuation‑catch‑up thesis.

Provides a detailed Q2 FY26 recap and full earnings‑call transcript, highlighting net income of $17.5 million ($0.35 per share), operating income of $21.6 million, a 27% gross margin, and a 9.4% operating margin achieved despite ~$8.8 million in tariff expense. Emphasizes 12% order growth, backlog expansion to $321 million (+36% year over year) with roughly half in live events, inventory and structural cost efficiencies, planned Saltillo, Mexico manufacturing capacity, and management’s long‑term targets for 7–10% revenue CAGR, 10–12% operating margins, and 17–20% ROIC by FY28.

Presents a deep fundamental thesis that Daktronics is a dominant but undervalued small‑cap industrial, citing a $360 million order backlog (after 35% year‑over‑year order growth), a fortress balance sheet with about $137 million in cash and minimal debt, high‑quality earnings with free cash flow roughly 7.6× net income, and cash‑flow‑based valuation metrics (EV/FCF ~12x) as evidence of mispricing. Discusses activist Alta Fox’s role, the new chairman’s commitment to closing the valuation gap, multi‑source valuation scores (S&P, ISS‑EVA, Jefferson Research, McLean Capital), and consensus price targets around $27–31, while explicitly addressing risks such as operating‑efficiency lagging, project cyclicality, tariff and supply‑chain exposure, and mixed ESG scores, but concluding these are manageable and more than discounted.